# Prospective Cohort of Patients Treated Using Neoadjuvant Modified FOLFIRINOX 6 Cycles for Potentially Resectable Pancreatic Duct Adenocarcinoma, Candidate for Participation in the PANACHE02 Clinical Trial

> **NCT07034703** · — · NOT_YET_RECRUITING · sponsor: **University Hospital, Rouen** · enrollment: 820 (estimated)

## Conditions studied

- Resectable Pancreatic Duct Adenocarcinoma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07034703
- **Lead sponsor:** University Hospital, Rouen
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-09
- **Primary completion:** 2030-09
- **Final completion:** 2032-01
- **Target enrollment:** 820 (ESTIMATED)
- **Last updated:** 2025-06-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07034703

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07034703, "Prospective Cohort of Patients Treated Using Neoadjuvant Modified FOLFIRINOX 6 Cycles for Potentially Resectable Pancreatic Duct Adenocarcinoma, Candidate for Participation in the PANACHE02 Clinical Trial". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT07034703. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*